Clinical Trials Browser

Phase 1/2 × MOC31PE immunotoxin × Gastrointestinal × Clear all

NCT02219893 2017-05-30

ImmunoPeCa

Phase 1/2 Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms